131
Views
5
CrossRef citations to date
0
Altmetric
Letter

Absence of BRAF and KRAS hotspot mutations in primary mediastinal B-cell lymphoma

, , , , &
Pages 2389-2390 | Received 27 Nov 2013, Accepted 16 Dec 2013, Published online: 04 Feb 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

David D. W. Twa & Christian Steidl. (2015) Structural genomic alterations in primary mediastinal large B-cell lymphoma. Leukemia & Lymphoma 56:8, pages 2239-2250.
Read now

Articles from other publishers (4)

Dipesh Uprety & Alex A. Adjei. (2020) KRAS: From undruggable to a druggable Cancer Target. Cancer Treatment Reviews 89, pages 102070.
Crossref
Fenja M Feld, Philipp D Nagel, Stephanie E Weissinger, Claudia Welke, Albrecht Stenzinger, Peter Möller & Jochen K Lennerz. (2015) GOT1/AST1 expression status as a prognostic biomarker in pancreatic ductal adenocarcinoma. Oncotarget 6:6, pages 4516-4526.
Crossref
P D Nagel, A Stenzinger, F M Feld, M D Herrmann, S Brüderlein, T F E Barth, R Marienfeld, V Endris, W Weichert, K-M Debatin, M-A Westhoff, D Lessel, P Möller & J K Lennerz. (2014) KIT mutations in primary mediastinal B-cell lymphoma. Blood Cancer Journal 4:8, pages e241-e241.
Crossref
Anna-Maria Bubolz, Stephanie E. Weissinger, Albrecht Stenzinger, Annette Arndt, Konrad Steinestel, Silke Brüderlein, Holger Cario, Anneli Lubatschofski, Claudia Welke, Ioannis Anagnostopoulos, Thomas F. E. Barth, Ambros J. Beer, Peter Möller, Martin Gottstein, Andreas Viardot & Jochen K. Lennerz. (2014) Potential clinical implications of BRAF mutations in histiocytic proliferations . Oncotarget 5:12, pages 4060-4070.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.